BOSTON--(BUSINESS WIRE)--
Vertex
Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that
management will present at the J.P. Morgan Healthcare Conference on
Monday, January 8, 2018 at 12:30 p.m. ET (9:30 a.m. PT). The audio
portion of management's remarks can be accessed live through Vertex's
website, www.vrtx.com
in the "Investors" section under the "News and Events" page.
In addition, the company announced today that it will report its
fourth-quarter and full-year 2017 financial results on Wednesday,
January 31 after the markets close. In conjunction with the
announcement, management will host a conference call that day at 4:30
p.m. ET. To participate in the conference call, please dial (866)
501-1537 (U.S.) or +1 (720) 545-0001 (International). The call will also
be available as a live and archived webcast on Vertex's website.
About Vertex
Vertex is a global biotechnology company that invests in scientific
innovation to create transformative medicines for people with serious
and life-threatening diseases. In addition to clinical development
programs in CF, Vertex has more than a dozen ongoing research programs
focused on the underlying mechanisms of other serious diseases.
Founded in 1989 in Cambridge, Mass., Vertex's headquarters is now
located in Boston's Innovation District. Today, the company has research
and development sites and commercial offices in the United States,
Europe, Canada and Australia. Vertex is consistently recognized as one
of the industry's top places to work, including being named to Science
magazine's Top Employers in the life sciences ranking for eight years in
a row. For additional information and the latest updates from the
company, please visit.
(VRTX-WEB)
View source version on businesswire.com: http://www.businesswire.com/news/home/20180103006183/en/
Vertex Pharmaceuticals Incorporated
Michael Partridge,
617-341-6108
or
Eric Rojas, 617-961-7205
or
Zach
Barber, 617-341-6470
Source: Vertex Pharmaceuticals Incorporated
News Provided by Acquire Media
